A flow cytometry test is a lab technique that identifies and counts individual cells in a sample of blood, bone marrow, or other body fluid. It works by passing cells one at a time through a laser beam, then measuring the light each cell produces to determine its type, size, and internal features. The test is most commonly used to help diagnose blood cancers like leukemia and lymphoma, and to monitor immune health in conditions like HIV.
How Flow Cytometry Works
A flow cytometer has three core systems working together: a fluidics system, an optical system, and an electronics system. The fluidics system uses pressurized saline fluid to funnel your cells into a single-file stream, delivering them one at a time to the point where the laser hits them. This sounds simple, but it’s critical. If cells clumped together, the machine couldn’t tell one from another.
The optical system does the actual measuring. Lasers strike each passing cell, and the light that bounces off or passes through is captured by a set of detectors. Light scattered at a low angle (called forward scatter) reveals a cell’s size. Light scattered at a wider angle (called side scatter) reveals the cell’s internal complexity, like whether it has a lot of internal structures or a relatively smooth interior. Different cell types have distinct size and complexity profiles, so these two measurements alone can separate red blood cells from white blood cells, or distinguish between types of white blood cells.
The electronics system converts all of those light signals into digital data a computer can analyze. The result is a detailed snapshot of thousands or even millions of individual cells, processed in seconds.
What Fluorescent Markers Add
Size and complexity only go so far. To precisely identify cell types, the lab tags your sample with fluorescent-labeled antibodies before running it through the machine. These antibodies are designed to latch onto specific proteins on the surface of cells (or sometimes inside them). Each antibody carries a fluorescent dye that glows a particular color when hit by the laser.
For example, a certain protein called CD4 sits on the surface of helper T cells, a key part of your immune system. An antibody tagged with a green fluorescent dye will bind only to cells carrying CD4. When those cells pass through the laser, the machine detects that green glow and counts them. Modern flow cytometers can detect multiple colors at once, meaning the lab can tag a single sample with several different antibodies and identify many cell types in one run. This process is called immunophenotyping.
Why Your Doctor Might Order This Test
The most common reason for a flow cytometry test is to diagnose or classify a blood cancer. Because leukemia and lymphoma involve abnormal white blood cells, immunophenotyping can identify exactly which type of white blood cell has become cancerous and how mature it is. This matters because different subtypes require different treatments. Flow cytometry can help distinguish between acute myeloid leukemia, B-cell and T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, mantle cell lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, and several other subtypes.
One notable exception: flow cytometry has historically not been very useful for diagnosing Hodgkin lymphoma, though newer methods are improving this. For certain myeloid cancers, the diagnosis relies more heavily on genetic testing and cell appearance under a microscope, with flow cytometry playing a supporting role.
Beyond initial diagnosis, flow cytometry is widely used to track minimal residual disease (MRD), which is the tiny number of cancer cells that may remain after treatment. The test can detect as few as 1 abnormal cell in 10,000 normal cells, and in some cases is sensitive enough to catch 1 in 100,000. This level of sensitivity helps doctors determine whether treatment is working and whether a relapse is likely.
Monitoring Immune Health in HIV
Flow cytometry plays a central role in managing HIV. The virus attacks CD4+ T cells, and as these cells decline, the risk of serious infections rises. Flow cytometry is the standard method for counting CD4+ T cells in a blood sample. Those counts are used to decide when to start preventive medications against opportunistic infections, to guide antiviral treatment decisions, and to track how well therapy is working over time. U.S. Public Health Service guidelines have recommended monitoring CD4+ T-cell levels every 3 to 6 months in all people living with HIV.
What the Sample Collection Looks Like
For most flow cytometry tests, you’ll have a standard blood draw. The lab needs at least 2 milliliters of blood collected in a specific tube containing an anticoagulant called EDTA (the lavender-topped tube you may have seen during routine blood work). If the test requires bone marrow, a doctor will perform a bone marrow aspirate, also collected in an EDTA tube, with a minimum of 2 mL.
Cerebrospinal fluid and other body fluids can also be tested. For time-sensitive cancers like Burkitt lymphoma, the sample needs to be kept cold and delivered to the lab within an hour of collection. For most other samples, the window is longer, typically within 24 hours.
How Results Are Analyzed
Once the machine collects data on your cells, a specialist reviews it using a process called gating. Think of gating as applying a series of digital filters to sort through the data. The first gate typically separates cells by size and internal complexity, isolating the cell population of interest (say, lymphocytes) from debris and other cell types. Subsequent gates narrow the focus further based on which fluorescent markers each cell is carrying.
The results appear as scatter plots, where each dot represents a single cell and its position reflects its characteristics. Clusters of dots in unexpected locations, or cells carrying unusual combinations of surface proteins, can signal a problem. The final report includes the percentages and absolute counts of each cell type identified, along with reference ranges showing what’s considered normal.
Turnaround Time
Flow cytometry results typically come back within a few days. Johns Hopkins Pathology, for instance, lists a 4-day turnaround for cerebrospinal fluid samples, with testing performed Monday through Saturday. Blood and bone marrow samples at many labs follow a similar timeline, though urgent cases can be prioritized. The actual time the cells spend in the machine is measured in minutes, but sample preparation, analysis by a trained specialist, and reporting add to the total wait.
Strengths and Limitations
Flow cytometry’s biggest strength is speed combined with precision. It can analyze thousands of cells per second and simultaneously measure multiple characteristics of each one. For blood cancers, it agreed with traditional tissue staining methods in 77% of cases in one standardization study, and was actually more sensitive in about 11% of cases, particularly for diffuse large B-cell lymphoma.
The test does have limits. It works best on cells that are already in suspension, like blood or bone marrow. Solid tissue samples need to be broken down into individual cells first, which can affect results. It also requires skilled interpretation. The gating process involves judgment calls, and international organizations like the European Society for Clinical Cell Analysis and the Clinical and Laboratory Standards Institute have been working to standardize how labs set up, validate, and report flow cytometry results to reduce variability between institutions.
For certain conditions, flow cytometry is one piece of a larger diagnostic puzzle. Myeloid cancers, for instance, rely more on genetic testing and microscopic examination. Plasma cell disorders can also be challenging to assess by flow cytometry alone. Your results will almost always be interpreted alongside other lab work, imaging, and clinical findings.